Risks and safety[edit | edit source]
Risks include the potential for addiction / substance abuse and tolerance. There are many side effects, including insomnia, irritability, dizziness, constipation, diarrhea, dyskinesia, dysphoria, headache, appetite loss, and heart palpitations.
Availability[edit | edit source]
Evidence[edit | edit source]
ME/CFS[edit | edit source]
Learn more[edit | edit source]
See also[edit | edit source]
References[edit | edit source]
- "Dexamfetamine". Drugs.com. Retrieved Sep 28, 2020.
- "DEXAMFETAMINE 5MG TABLETS". Drugs.com. Retrieved Sep 28, 2020.
- Carruthers, Bruce M.; Jain, Anil Kumar; De Meirleir, Kenny L.; Peterson, Daniel L.; Klimas, Nancy G.; Lerner, A. Martin; Bested, Alison C.; Flor-Henry, Pierre; Joshi, Pradip; Powles, A C Peter; Sherkey, Jeffrey A.; van de Sande, Marjorie I. (2003), "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols" (PDF), Journal of Chronic Fatigue Syndrome, 11 (2): 7-115, doi:10.1300/J092v11n01_02
adverse reaction - Any unintended or unwanted response to the treatment under investigation in a clinical trial.
chronic fatigue syndrome (CFS) - A fatigue-based illness. The term CFS was invented invented by the U.S. Centers for Disease Control as an replacement for myalgic encephalomyelitis (ME). Some view CFS as a neurological disease, others use the term for any unexplained long-term fatigue. Sometimes used as a the term as a synonym of myalgic encephalomyelitis, despite the different diagnostic criteria.